Mankind Pharma Ltd share price logo

Mankind Pharma Ltd Share Price (MANKIND)

Mid Cap

Healthcare Sector

Check the latest share price of Mankind Pharma Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹2526.6▲3.9%

as on 04:01PM, 09 Jul 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Option Chain

Mankind Pharma Ltd Stock Performance

Get live Mankind Pharma Ltd share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹2,417.6
    Day's Price Range
    ₹2,543.6

  • 52 Week's Low

    52 Week's High

    ₹1,901.05
    52-Week Price Range
    ₹3,054.8
1 Month Return+ 3.18 %
3 Month Return+ 5.09 %
1 Year Return+ 15.66 %
3 Year Return+ 70.97 %
5 Year Return+ 70.97 %
Previous Close₹2,431.70
Open₹2,419.50
Volume14.49L
Upper Circuit₹2,674.80
Lower Circuit₹2,188.60

Mankind Pharma Ltd Fundamentals & Key Indicators

Check Mankind Pharma Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹1,00,363.25 Cr

Return on Equity (ROE)

20.95

PE Ratio (TTM)

49.27

Return on capital employed (ROCE)

25.77

Industry PE ratio

52.61

Beta (LTM)

0.63

P/B Ratio

9.56

Dividend Yield

0

PEG Ratio

30.8

Quarterly Earnings Growth YOY

-10.9

EPS (TTM)

48.47

Sector

Pharmaceuticals

Book Value

233.73

Technical Analysis

Bullish

View Technical Analysis

How to invest in Mankind Pharma Ltd?

Investing in Mankind Pharma Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Mankind Pharma Ltd or MANKIND on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Mankind Pharma Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Mankind Pharma Ltd with just a few clicks!

Mankind Pharma Ltd Stock's Interest Amongst Investors

-7.54%

Period Jul 09, 2025 to Jun 09, 2025. Change in 30 Days vs previous period

Investment in Mankind Pharma Ltd Shares on INDmoney has dropped by -7.54% over the past 30 days, indicating reduced transactional activity.

9%

Period Jul 09, 2025 to Jun 09, 2025. Change in 30 Days vs previous period

Search interest for Mankind Pharma Ltd Stock has increased by 9% in the last 30 days, reflecting an upward trend in search activity.

Mankind Pharma Ltd Valuation

Track how Mankind Pharma Ltd P/E has moved over time to understand its valuation trends.

Mankind Pharma Ltd in the last 5 years

  • Overview

  • Trends

Lowest (40.63x)

August 5, 2024

Today (49.27x)

July 8, 2025

Industry (52.61x)

July 8, 2025

Highest (57.69x)

January 3, 2025

LowHigh

Today’s Price to Earnings Ratio: 49.27x

Mankind Pharma Ltd Stock Recommendation

Get updated buy, sell, and hold recommendations by analysts on Mankind Pharma Ltd.

based on 17 analysts

BUY

76.47%

Buy

11.76%

Hold

11.76%

Sell

76.47% of analysts recommend a 'BUY' rating for Mankind Pharma Ltd. Average target price of ₹2712.47

Source: S&P Global Market Intelligence

Mankind Pharma Ltd Share Price Target

Get share price movements and forecasts by analysts on Mankind Pharma Ltd.

Mankind Pharma Ltd price forecast by 17 analysts

Upside of11.55%

High

₹3300

Target

₹2712.47

Low

₹2150

Mankind Pharma Ltd target price ₹2712.47, a slight upside of 11.55% compared to current price of ₹2526.6. According to 17 analysts rating.

Source: S&P Global Market Intelligence

Mankind Pharma Ltd Financial Results

Get the annual and quarterly financial summary of Mankind Pharma Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

2422 (0%)2893 (19%)3077 (6%)3199 (4%)3079 (4%)
Net Income

(in ₹ Cr)

477 (0%)543 (14%)659 (21%)385 (42%)425 (10%)
Net Profit Margin19.68% (0%)18.77% (5%)21.42% (14%)12.02% (44%)13.79% (15%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

5990 (0%)9104 (52%)9634 (6%)11765 (22%)
Total Liabilities

(in ₹ Cr)

1256 (0%)2564 (104%)1851 (28%)2141 (16%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

960 (0%)983 (2%)821 (16%)1799 (119%)1983 (10%)

Indices Featuring Mankind Pharma Ltd Stock

Check stock indices that include Mankind Pharma Ltd.

Nifty Healthcare

₹14,534.90

-0.36 (▲-53.2%)

S&P BSE 100 LargeCap TMC

₹9,406.23

-0.2 (▲-19.09%)

BSE 200

₹11,561.13

-0.18 (▲-20.28%)

BSE Healthcare

₹44,480.38

-0.08 (▲-34.66%)

Nifty 200

₹14,211.15

-0.16 (▲-22.1%)

Nifty LargeMidcap 250

₹16,513.15

-0.1 (▲-16.15%)

S&P BSE Largecap

₹9,810.67

-0.18 (▲-17.76%)

S&P BSE 250 LargeMidCap

₹10,963.93

-0.16 (▲-17.57%)

Nifty Midcap 100

₹59,339.60

-0.13 (▲-75.85%)

BSE 500

₹36,963.79

-0.1 (▲-35.23%)

NIFTY PHARMA

₹22,208.50

0.19 (▲42.6%)

Nifty Midcap 150

₹21,878.65

-0.03 (▲-7.5%)

Nifty MidSmallcap 400

₹20,433.65

0.17 (▲35.6%)

Nifty 500

₹23,557.45

-0.06 (▲-15.1%)

Mankind Pharma Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Mankind Pharma Ltd.

  • Mankind Pharma Ltd Earnings Results

    Mankind Pharma Ltd’s net profit fell -10.71% since last year same period to ₹420.77Cr in the Q4 2024-2025. On a quarterly growth basis, Mankind Pharma Ltd has generated 10.66% jump in its net profits since last 3-months.

    Read More about Earnings Results

Mankind Pharma Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Mankind Pharma Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
72.7%
0.00
Foreign Institutions
12.92%
0.00
Mutual Funds
7.67%
0.00
Retail Investors
2.9%
0.00
Others
3.81%
0.00

Mankind Pharma Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Mankind Pharma Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Mankind Pharma Ltd
Mankind Pharma Ltd
BUY1,00,363.2514.19%0.511,94110,334
Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd
BUY55,238.2324.23%0.569273,749
Ipca Laboratories Ltd
Ipca Laboratories Ltd
BUY37,172.7415.58%0.585297,705
Biocon Ltd
Biocon Ltd
BUY49,380.75-1.8%0.581,29714,755
Lupin Ltd
Lupin Ltd
BUY87,785.4124.34%0.511,93520,010
See all

Mankind Pharma Ltd News & Key Events

Latest news and events in one place to help you make informed investing decisions in Mankind Pharma Ltd.

  • Rajkummar Rao Becomes Brand Ambassador for Nimulid Strong - 25 Jun, 2025

    Mankind Pharma has appointed Rajkummar Rao as the brand ambassador for Nimulid Strong, a pain relief gel and spray. This partnership aims to position Nimulid Strong as a trusted solution for neck pain relief, emphasizing its quick action and effective formulation.

  • Mankind Pharma Reports Mixed Financial Results - 24 Jun, 2025

    Mankind Pharma's consolidated net sales for March 2025 reached Rs 3,079.37 crore, up 26.15% year-on-year. However, net profit declined by 10.71% to Rs 420.77 crore, and EPS fell to Rs 10.20. EBITDA increased by 36.78%.

  • Mankind Pharma Launches Father's Day Campaign - 13 Jun, 2025

    Mankind Pharma has launched a Father's Day campaign for HealthOK multivitamin tablets, celebrating fathers as HealthOK Heroes. The initiative emphasizes the importance of fathers' well-being and its connection to their children's health, supported by marketing across digital and traditional platforms.

  • Mankind Pharma Allocates Shares Under ESOP - 10 Jun, 2025

    Mankind Pharma has allotted 57,709 equity shares under its ESOP Plan, increasing its paid-up share capital. This move reflects the company's commitment to employee incentives.

Insights on Mankind Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 5 quarters, 2.51K Cr → 3.33K Cr (in ₹), with an average increase of 6.6% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, MANKIND stock has moved up by 2.0%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 380.23 Cr → 420.77 Cr (in ₹), with an average increase of 9.6% per quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 2.90% of holdings in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 13.34% to 12.92% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 72.71% to 72.70% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 7.83% to 7.67% in Mar 2025 quarter

About Mankind Pharma Ltd

Mankind Pharma Ltd. was established in 1991 as a Private Limited Company. In 2005 it was converted to a Public Limited Company and the name changed to Mankind Pharma Limited. The Company is engaged in the development, manufacturing and marketing of a range of pharmaceuticals and consumer healthcare products, and is active in acute and chronic therapeutic areas such as anti-infectives, cardiovascular and gastrointestinal treatments, antidiabetic and neuro/CNS medicines, vitamins, minerals and nutrients. In 2004, they entered the chronic pharmaceutical segment, and have added further products over the years, including ophthalmic products, consumer healthcare products, animal healthcare products and specialty therapeutic divisions. They operate 23 manufacturing facilities across India and had 2181 manufacturing personnel as of March 31, 2021. It is now planning to raise capital through the public offering of 40058844 equity shares, with a total installed capacity of 40.77 billion units across a range of products.

Revenue: ₹3,079.37Cr as on March 2025 (Q4 FY25)
Net Profit: ₹424.65Cr as on March 2025 (Q4 FY25)
Listing date: 09 May, 2023
Chairperson Name: RAMESH CHAND JUNEJA
OrganisationMankind Pharma Ltd
HeadquartersNew Delhi
IndustryPharmaceuticals
CEORAMESH CHAND JUNEJA
E-voting on sharesClick here to vote

Mutual Funds that own Mankind Pharma Ltd

Check out the Mutual Funds with significant holdings in Mankind Pharma Ltd.

FAQs

What is Mankind Pharma Ltd share price today?

Mankind Pharma Ltd share price today stands at ₹2526.6, Open: ₹2419.5, Previous Close: ₹2431.7, High: ₹2543.6, Low: ₹2417.6, 52 Week High: ₹3054.8, 52 Week Low: ₹1901.05.

What is today's traded volume of Mankind Pharma Ltd?

Today's traded volume of Mankind Pharma Ltd is 14.49L. Which means that 14.49L shares of Mankind Pharma Ltd were bought and sold on the stock market during today's trading session.

What is Mankind Pharma Ltd's market cap today?

Today's market capitalisation of Mankind Pharma Ltd is ₹1,00,363.25 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Mankind Pharma Ltd?

Mankind Pharma Ltd’s 52 week high is ₹3054.8 and 52 week low is ₹1901.05. The current share price of Mankind Pharma Ltd is ₹2526.6, which is -17.29% down from its 52 week high and 32.91% up from its 52 week low.